Mounjaro 15 mg: la pluma precargada contiene 15 mg de tirzepatida en 0,5 ml de solucin (30 mg/ml)
"We may start with oral agents, then move on to GLP-1s, and then ultimately we may need to move on to basal or even bolus insulin
Disadvantages: Absorption : Oral supplements may have lower absorption rates compared to injectables due to digestive system breakdown
The safety and tolerability of semaglutide in this population will be elucidated in these trials
Patients taking Mounjaro should be aware of the following signs and symptoms: Common symptoms of iron deficiency include: Persistent fatigue and weakness that seems disproportionate to activity levels Pallor (pale skin, conjunctiva, or nail beds) Shortness of breath , particularly with exertion Dizziness or lightheadedness Cold hands and feet Headaches Rapid or irregular heartbeat (palpitations) More specific signs that may develop with established iron deficiency include: Brittle nails or koilonychia (spoon-shaped nails) Angular cheilitis (cracks at the corners of the mouth) Glossitis (sore, smooth tongue) Restless legs syndrome Unusual cravings for non-food items (pica), such as ice, clay, or starch Difficulty concentrating or cognitive impairment It is important to note that fatigue is also a recognised side effect of Mounjaro itself, particularly during the initial weeks of treatment

Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP and GLP-1 receptor agonist that has transformed metabolic medicine